# Data Sciences International

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/data-sciences-international

- Industry: Pharmaceuticals
- Headquarters: St. Paul, US
- Website: www.datasci.com
- Total disclosed funding: $12M
- Latest round: Series A (Feb 5, 2002)
- Investors on record: 2

## About

Data Sciences International (DSI) focuses on advanced physiological monitoring solutions for laboratory animal research, enhancing data accuracy and consistency through innovative telemetry systems.Data Sciences International, headquartered in St. Paul, US, was founded in 1984. The company specializes in physiological monitoring solutions, notably wireless telemetry systems for real-time data collection in whole animal physiology studies. DSI was involved in a deal with Harvard Bioscience in January 2018, where it was acquired for USD 70 million.Data Sciences International (DSI) offers advanced physiological monitoring solutions tailored for laboratory animal research. Their primary products include wireless telemetry systems that monitor various physiological parameters essential for whole animal physiology studies. DSI's offerings support New Approach Methodologies (NAMs) to improve data accuracy in preclinical research, serving clients across academia, pharmaceuticals, and research organizations in cardiometabolic, neuroscience, and inhalation studies. The company distributes its products throughout North America, Europe, and Asia, addressing global research needs.DSI generates revenue from direct sales of its specialized monitoring equipment and software solutions to research institutions. They engage in B2B transactions where clients either make outright purchases or enter into partnership agreements for ongoing software support. Their pricing models include one-time purchases for products like the SoHo Implantable Telemetry and subscription services for software updates, facilitating seamless integration with clients' research protocols.Looking ahead, Data Sciences International plans to expand its product lineup by developing new monitoring technologies, aiming for a launch in 2023. The company intends to enter new markets in Southeast Asia and Europe by 2024, utilizing the recent funding of USD 12.000 mn from the Series A round led by Polaris Partners, which will support these initiatives. The funding will facilitate the research and development of innovative products as well as the expansion of their global presence.

## Funding rounds

- Series A, Feb 5, 2002, $12M — Canaan Partners, Polaris Partners

## Investors

- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series A
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series A